178 related articles for article (PubMed ID: 17559623)
1. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
2. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
3. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
4. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
César-Neto JB; Duarte PM; de Oliveira MC; Tambeli CH; Sallum EA; Nociti FH
J Periodontal Res; 2007 Apr; 42(2):184-91. PubMed ID: 17305878
[TBL] [Abstract][Full Text] [Related]
5. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.
Wara-aswapati N; Surarit R; Chayasadom A; Boch JA; Pitiphat W
J Periodontol; 2007 Jun; 78(6):1062-9. PubMed ID: 17539720
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease.
Garlet GP; Martins W; Fonseca BA; Ferreira BR; Silva JS
J Clin Periodontol; 2004 Aug; 31(8):671-9. PubMed ID: 15257746
[TBL] [Abstract][Full Text] [Related]
7. High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes.
Vernal R; Dutzan N; Hernández M; Chandía S; Puente J; León R; García L; Del Valle I; Silva A; Gamonal J
J Periodontol; 2006 Oct; 77(10):1772-80. PubMed ID: 17032122
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
[TBL] [Abstract][Full Text] [Related]
9. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
[TBL] [Abstract][Full Text] [Related]
11. The potential role of interleukin-17 in the immunopathology of periodontal disease.
Takahashi K; Azuma T; Motohira H; Kinane DF; Kitetsu S
J Clin Periodontol; 2005 Apr; 32(4):369-74. PubMed ID: 15811054
[TBL] [Abstract][Full Text] [Related]
12. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease.
Nagasawa T; Kiji M; Yashiro R; Hormdee D; Lu H; Kunze M; Suda T; Koshy G; Kobayashi H; Oda S; Nitta H; Ishikawa I
Periodontol 2000; 2007; 43():65-84. PubMed ID: 17214836
[No Abstract] [Full Text] [Related]
13. Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression?
Garlet GP; Cardoso CR; Campanelli AP; Martins W; Silva JS
J Periodontal Res; 2006 Dec; 41(6):580-4. PubMed ID: 17076785
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinases mediate interleukin-1beta-induced receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells.
Oikawa A; Kobayashi M; Okamatsu Y; Shinki T; Kamijo R; Yamamoto M; Hasegawa K
J Periodontal Res; 2007 Aug; 42(4):367-76. PubMed ID: 17559635
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
Mogi M; Otogoto J; Ota N; Togari A
J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
[TBL] [Abstract][Full Text] [Related]
16. RANKL in human periapical granuloma: possible involvement in periapical bone destruction.
Vernal R; Dezerega A; Dutzan N; Chaparro A; León R; Chandía S; Silva A; Gamonal J
Oral Dis; 2006 May; 12(3):283-9. PubMed ID: 16700737
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
18. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients.
Lappin DF; Sherrabeh S; Jenkins WM; Macpherson LM
J Clin Periodontol; 2007 Apr; 34(4):271-7. PubMed ID: 17378883
[TBL] [Abstract][Full Text] [Related]
19. Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis.
Mogi M; Otogoto J
Arch Oral Biol; 2007 Sep; 52(9):894-8. PubMed ID: 17321485
[TBL] [Abstract][Full Text] [Related]
20. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction.
Liu D; Xu JK; Figliomeni L; Huang L; Pavlos NJ; Rogers M; Tan A; Price P; Zheng MH
Int J Mol Med; 2003 Jan; 11(1):17-21. PubMed ID: 12469211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
